Storia in 12 fonti

FDA drug center head fired after commissioner's exit, replaced by Davis

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner Marty Makary's exit amid agency-wide shifts. Karim Mikhail now leads the biologics center, and Lowell Zeta is acting chief of staff. Hoeg's tenure included efforts to revise childhood vaccination schedules.

Raccontata da

economictimes.indiatimes.com

medpagetoday.com

pharmaceutical-technology.com

giovedì 14 maggio 2026·thedispatch.com
Marty Makary’s Turbulent Tenure at FDA Comes to an End
Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.
venerdì 15 maggio 2026·fiercepharma.com
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA. | With the ink barely dry on outgoing…

FDA drug center head fired after commissioner's exit, replaced by Davis

Marty Makary’s Turbulent Tenure at FDA Comes to an End

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

FDA leadership shake-up continues with departure of top drug regulator

FDA shuffles top drug, biologics leaders in latest shakeup

Controversial FDA official leaving drug center post in latest departure at agency

FDA official key to vaccine schedule overhaul to depart

FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up

FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above' -

RFK ally confirms she was fired by FDA: 'I learned so much and leave with no regrets' | Fortune

FDA drug center head fired after commissioner's exit, replaced by Davis

FDA Official Who Scrutinized COVID Shots, Antidepressants Is Out in Latest Shake-Up

Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup - Pharmaceutical Technology

Who Will Be FDA's Next Commissioner?